Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn

被引:96
作者
Bloch-Queyrat, C
Fondanèche, MC
Chen, RY
Yin, L
Relouzat, F
Veillette, A
Fischer, A
Latour, S [1 ]
机构
[1] Hop Necker Enfants Malad, Lab Dev Normal & Pathol Syst Immunitaire, INSERM, U 429, F-75015 Paris, France
[2] Int Agcy Res Canc, F-69372 Lyon, France
[3] Clin Res Inst Montreal, Montreal, PQ H3G 146, Canada
关键词
D O I
10.1084/jem.20050449
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SAP is an adaptor protein that is expressed in NK and T cells. It is mutated in humans who have X-linked lymphoproliferative (XLP) disease. By interacting with SLAM family receptors, SAP enables tyrosine phosphorylation signaling of these receptors by its ability to recruit the Src-related kinase, Fyn. Here, we analyzed the role of SAP in NK cell functions using the SAP-deficient mouse model. Our results showed that SAP was required for the ability of NK cells to eliminate tumor cells in vitro and in vivo. This effect strongly correlated with expression of CD48 on tumor cells, the ligand of 2B4, a SLAM-related receptor expressed in NK cells. In keeping with earlier reports that studied human NK cells, we showed that SAP was necessary for the ability of 2B4 to trigger cytotoxicity and IFN-gamma secretion. In the absence of SAP, 2B4 function was shifted toward inhibition of NK cell-mediated cytotoxicity. By analyzing mice lacking Fyn, we showed that similarly to SAP, Fyn was strictly required for 2B4 function. Taken together, these results provide evidence that the 2B4-SAP-Fyn cascade defines a potent activating pathway of natural cytotoxicity. They also could help to explain the high propensity of patients who have XLP disease to develop lymphoproliferative disorders.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 41 条
[1]   Cutting edge: Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family [J].
Bouchon, A ;
Cella, M ;
Grierson, HL ;
Cohen, JI ;
Colonna, M .
JOURNAL OF IMMUNOLOGY, 2001, 167 (10) :5517-5521
[2]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090
[3]   Molecular dissection of 2134 signaling: Implications for signal transduction by SLAM-related receptors [J].
Chen, RY ;
Relouzat, F ;
Roncagalli, R ;
Aoukaty, A ;
Tan, RS ;
Latour, S ;
Veillette, A .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (12) :5144-5156
[4]   Natural killer cell activation in mice and men: different triggers for similar weapons? [J].
Colucci, F ;
Di Santo, JP ;
Leibson, PJ .
NATURE IMMUNOLOGY, 2002, 3 (09) :807-813
[5]   Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases [J].
Colucci, F ;
Schweighoffer, E ;
Tomasello, E ;
Turner, M ;
Ortaldo, JR ;
Vivier, E ;
Tybulewicz, VLJ ;
Di Santo, JP .
NATURE IMMUNOLOGY, 2002, 3 (03) :288-294
[6]   Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to Src-related kinase FynT in TH2 cytokine regulation [J].
Davidson, D ;
Shi, XC ;
Zhang, SH ;
Wang, H ;
Nemer, M ;
Ono, N ;
Ohno, SJ ;
Yanagi, Y ;
Veillette, A .
IMMUNITY, 2004, 21 (05) :707-717
[7]   Defective cytotoxic granule-mediated cell death pathway impairs T lymphocyte homeostasis [J].
de Saint Basile, G ;
Fischer, A .
CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (04) :436-445
[8]   Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages [J].
Diefenbach, A ;
Jamieson, AM ;
Liu, SD ;
Shastri, N ;
Raulet, DH .
NATURE IMMUNOLOGY, 2000, 1 (02) :119-126
[9]   A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity [J].
Diefenbach, A ;
Hsia, JK ;
Hsiung, MYB ;
Raulet, DH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (02) :381-391
[10]   SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells [J].
Dupré, L ;
Andolfi, G ;
Tangye, SG ;
Clementi, R ;
Locatelli, F ;
Aricò, M ;
Aiuti, A ;
Roncarolo, MG .
BLOOD, 2005, 105 (11) :4383-4389